Retraction
Effects of Afatinib on Development of Non-Small-Cell Lung Cancer by Regulating Activity of Wnt/β-Catenin Signaling Pathway
Paper Information
Record ID:
41994
Author(s):
Publication Date:
June 28, 2022
Retraction Date:
December 28, 2022
(2.9 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (3)
3
Total Citations0
Post-Retraction1
Pre-Retraction1
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retracted: Effects of Afatinib on Development of Non-Small-Cell Lung Cancer by Regulating Activity of Wnt/<i>β</i>-Catenin Signaling Pathway
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Dec 2022
Same day as retraction
miR‑29a‑3p inhibits the malignant characteristics of non‑small cell lung cancer cells by reducing the activity of the Wnt/β‑catenin signaling pathway
Kang Zhang, Xiaoliang Han, Wenbin Hu et al. (5 authors)
Oncology Letters
Open Access
Published: Sep 2022
12 citations
12 citations
107 days before retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025